18 reports

Combination of approved immunotherapies with new in-research immunotherapies has resulted in improved response rates for patients with RCC.

  • Cancer
  • Immunotherapy
  • Renal Cancer
  • Therapy
  • Genentech, Inc.
  • Debio-1143

Subjects were randomized in a ##:##:## ratio to receive no additional treatment, one year of Herceptin treatment or two years of Herceptin treatment.

  • Breast Cancer
  • Immunotherapy
  • Targeted Therapy
  • Therapy
  • Genentech, Inc.

Indian Journal of Ophthalmology; ##(##): ## Pfizer.

  • Immunotherapy
  • Pharmaceutical
  • Therapy
  • Clearside Biomedical, Inc.
  • Genentech, Inc.

From tool to therapy: a timeline of monoclonal antibody technology.

  • Immunotherapy
  • Medical Biotechnology
  • Monoclonal Antibody
  • Genentech, Inc.
  • Schering-Plough Corporation

The use of antibody conjugates is growing, including in therapies such as radio immunotherapy and antibody-directed enzyme prodrug therapy.

  • Immunotherapy
  • Therapy
  • United States
  • World
  • Genentech, Inc.

CAMBRIDGE ANTIBODY TECHNOLOGY ##.

  • Clinical Trial
  • Immunotherapy
  • Pharmaceutical
  • Therapy
  • Genentech, Inc.

VAXIMM will be responsible for conducting two open-label Phase I/ II trials - one in glioblastoma and one in metastatic colorectal cancer.

  • Immunotherapy
  • Therapy
  • Genentech, Inc.
  • Roche Group
  • Schering-Plough Corporation

Atezolizumab will be the first immunotherapy available for TNBC patients in the firstline setting.

  • Breast Cancer
  • Immunotherapy
  • Targeted Therapy
  • Therapy
  • Genentech, Inc.

Nanda on Immunotherapy in Metastatic TNBC.

  • Breast Cancer
  • Immunotherapy
  • Targeted Therapy
  • Therapy
  • Genentech, Inc.
  • T-Cell Redirecting Bispecific Cancer Antibodies - 5/30

Product ABBVIE - ##/ ## ID No.

  • Cancer
  • Immunotherapy
  • Affimed Therapeutics AG
  • Genentech, Inc.
  • Schering-Plough Corporation
  • T-Cell Redirecting Bispecific Cancer Antibodies - 5/30

Product ABBVIE - ##/ ## ID No.

  • Cancer
  • Immunotherapy
  • Affimed Therapeutics AG
  • Genentech, Inc.
  • Schering-Plough Corporation

Two patients also received prior immunotherapy.

  • Healthcare
  • Immunotherapy
  • Pharmaceutical
  • Therapy
  • Genentech, Inc.
  • Early-Stage Pipeline Products in Non-Hodgkin's Lymphoma

TERM=RICER& RANK=##.

  • Epidemiology
  • Immunotherapy
  • Lymphoma
  • Therapy
  • Genentech, Inc.

RORg Agonists as a Novel Immunotherapy Approach for Cancer Annual Meeting of the American Association for Cancer Research (AACR); Philadelphia, PA, USA; Apr ## - ##, 2015a: abstract ## and Poster Hu X, Moisan J, Majchrzak K et al.

  • Immunotherapy
  • Pharmaceutical
  • 4SC Discovery GmbH
  • Advinus
  • Genentech, Inc.

GBR ## is based on Glenmark' s innovative BEAT antibody technology platform.

  • Biosimilar
  • Immunotherapy
  • Genentech, Inc.
  • Glenmark Pharmaceuticals Ltd.
  • Roche Group

ROCHE - ##/ ## Product ROCHE - ##/ ## ID No.

  • Immunotherapy
  • Medical Biotechnology
  • Biogen Idec Inc.
  • Boehringer Ingelheim GmbH
  • Genentech, Inc.

" Immunotherapy treatments offer enormous promise in the treatment of lung cancer.

  • Immunotherapy
  • Monoclonal Antibody
  • Targeted Therapy
  • United States
  • Genentech, Inc.
  • Business Segment Analysis

TALIMOGENE LAHERPAREPVEC IS AN ONCOLYTIC IMMUNOTHERAPY DERIVED FROM HSV-##.

  • Healthcare
  • Immunotherapy
  • Pharmaceutical
  • United States
  • Genentech, Inc.